Version Changes
Revised. Amendments from Version 1
Table 1 - studies related to financial incentives and flu immunization have been removed as they are not relevant. Methods section - the first sentence under search strategy and selection criteria has been updated to specify the scope of research further. Results section - added more details on maternal education. Discussion section - first sentence has been updated to keep description of intervention domains consistent with the introduction. References section - 4 references removed in order to be consistent with Table 1.
Abstract
Background: Improving the health of pregnant women is important to prevent adverse birth outcomes, such as preterm birth and low birthweight. We evaluated the comparative effectiveness of interventions under the domains of micronutrient, balanced energy protein, deworming, maternal education, and water sanitation and hygiene (WASH) for their effects on these adverse birth outcomes.
Methods: For this network meta-analysis, we searched for randomized clinical trials (RCTs) of interventions provided to pregnant women in low- and middle-income countries (LMICs). We searched for reports published until September 17, 2019 and hand-searched bibliographies of existing reviews. We extracted data from eligible studies for study characteristics, interventions, participants’ characteristics at baseline, and birth outcomes. We compared effects on preterm birth (<37 gestational week), low birthweight (LBW; <2500 g), and birthweight (continuous) using studies conducted in LMICs.
Results: Our network meta-analyses were based on 101 RCTs (132 papers) pertaining to 206,531 participants. Several micronutrients and balanced energy food supplement interventions demonstrated effectiveness over standard-of-care. For instance, versus standard-of-care, micronutrient supplements for pregnant women, such as iron and calcium, decreased risks of preterm birth (iron: RR=0.70, 95% credible interval [Crl] 0.47, 1.01; calcium: RR=0.76, 95%Crl 0.56, 0.99). Daily intake of 1500kcal of local food decreased the risks of preterm birth (RR=0.36, 95%Crl 0.16, 0.77) and LBW (RR=0.17, 95%Crl 0.09, 0.29), respectively when compared to standard-of-care. Educational and deworming interventions did not show improvements in birth outcomes, and no WASH intervention trials reported on these adverse birth outcomes.
Conclusion: We found several pregnancy interventions that improve birth outcomes. However, most clinical trials have only evaluated interventions under a single domain (e.g. micronutrients) even though the causes of adverse birth outcomes are multi-faceted. There is a need to combine interventions that of different domains as packages and test for their effectiveness.
Registration: PROSPERO CRD42018110446; registered on 17 October 2018.
Keywords: Pregnancy, low- and middle-income countries, network meta-analysis, evidence synthesis, preterm, birthweight, birth outcomes
Introduction
Despite global substantial progresses that have been made towards improving maternal, newborn, and child health (MNCH) in the last two decades, adverse birth outcomes such as preterm birth and low birthweight still remain as an important global health challenge, particularly in low- and middle-income countries (LMIC) 1– 3. Determinants of these challenges are multifaceted 4– 7. Pregnant women in LMICs have a higher risk of nutritional deficiencies, stemming from physiological changes that involve fetal development and growth resulting in an increased demand for nutrients 4, 5. Poor water, sanitation, and hygiene (WASH) control can also increase likelihood for infectious diseases, including intestinal worm infections that may contribute to conditions, such as anemia, which negatively affects fetal survival and growth 6, 8, 9. Poor maternal health during pregnancy is associated with preterm birth (<37 gestation weeks) and low birthweight (<2500 g), and these adverse birth outcomes are associated with adverse neonatal events, such as respiratory distress syndrome, neurocognitive impairment, poor linear growth (stunting), and overall mortality 1, 2, 10, 11.
Several reviews have aimed to assess the effectiveness of various promising interventions for pregnant women ( Table 1). Despite the extensive research conducted to date, the comparative effectiveness of interventions remains unclear across different domains, such as micronutrients, balanced energy protein supplements, maternal education, deworming, and WASH. Few clinical trials have directly compared interventions across domains. Rather, the majority of clinical trials has only compared interventions within a domain. Similarly, most summaries of the evidence for pregnancy interventions have used traditional pairwise meta-analysis, allowing only for the quantitative assessment of a single intervention versus a comparator. Thus far, no attempts have been made to synthesize the evidence indirectly in order to make quantitative comparison of interventions that have not been directly compared in studies.
Table 1. Existing reviews on interventions for pregnant women.
Review ID | Title | Interventions | No of studies | Types of studies
included |
---|---|---|---|---|
Imdad 2011 20 | Effect of balanced protein energy
supplementation during pregnancy on birth outcomes |
Balanced protein
energy supplements |
11 | RCTs and quasi-RCTs |
Imdad 2012 21 | Maternal Nutrition and Birth Outcomes: Effect
of Balanced Protein-Energy Supplementation |
Balanced protein
energy supplements |
16 | RCTs and quasi-RCTs |
Liberato 2013 22 | Effects of protein energy supplementation
during pregnancy on fetal growth: a review of the literature focusing on contextual factors |
Balanced protein
energy supplements |
20 | RCTs, quasi-RCTs, and
observational study |
Stevens 2015 23 | The effect of balanced protein energy
supplementation in undernourished pregnant women and child physical growth in low- and middle-income countries: a systematic review and meta-analysis |
Balanced protein
energy supplements |
7 | RCTs, quasi-RCTs, and
observational study |
Buppasiri 2015 24 | Calcium supplementation (other than for
preventing or treating hypertension) for improving pregnancy and infant outcomes |
Calcium | 25 | RCTs and cluster-RCTs |
Hofmeyr 2014 25 | Calcium supplementation during pregnancy for
preventing hypertensive disorders and related problems |
Calcium | 13 | RCTs |
Salam 2015 26 | Effect of administration of antihelminthics for
soil-transmitted helminths during pregnancy |
Deworming | 4 | RCTs |
Lassi 2013 27 | Folic acid supplementation during pregnancy
for maternal health and pregnancy outcomes |
Folic acid | 31 | RCTs and cluster-RCTs |
Yang 2011 28 * | Review of fortified food and beverage products
for pregnant and lactating women and their impact on nutritional status |
Fortified products | 14 | RCT, quasi-RCT |
Pena-Rosas 2009 29 | Effects and safety of preventive oral iron or
iron+folic acid supplementation for women during pregnancy |
Iron; Iron + folic acid | 49 | RCTs and quasi-RCTs |
Suchdev 2015 30 | Multiple micronutrient powders for home
(point-of-use) fortification of foods in pregnant women (Review) |
Multiple
micronutrient powders |
2 | RCTs |
Haider 2017 31 | Multiple-micronutrient supplementation for
women during pregnancy |
Multiple
micronutrient supplements |
19 | RCTs |
Imhoff-Kunsch 2012 32 | Effect of n-3 Long-chain Polyunsaturated
Fatty Acid Intake during Pregnancy on Maternal, Infant, and Child Health Outcomes: A Systematic Review |
N-3 long chain
polyunsaturated fatty acid |
15 | RCT |
Thorne-Lyman
2012A 33 |
Vitamin A and carotenoids during pregnancy
and maternal, neonatal and infant health outcomes: a systematic review and meta- analysis |
Vitamin A | 17 | RCTs |
De-Regil 2016 34 | Vitamin D supplementation for women during
pregnancy |
Vitamin D | 15 | RCTs and quasi-RCTs |
Perez-Lopez 2015 35 | Effect of vitamin D supplementation during
pregnancy on maternal and neonatal outcomes: a systematic review and meta- analysis of randomized controlled trials |
Vitamin D | 13 | RCTs |
Thorne-Lyman
2012B 36 |
Vitamin D during pregnancy and maternal,
neonatal and infant health outcomes: a systematic review and meta-analysis |
Vitamin D | 5 | RCTs |
Ota 2015 37 | Zinc supplementation for improving pregnancy
and infant outcome |
Zinc | 21 | RCTs |
Goudet 2019 38 | Nutritional interventions for preventing stunting
in children (birth to 59 months) living in urban slums in low-and middle-income countries (lmic) |
Nutrient
supplementation and Education |
15 | RCTs, quasi-RCTs, non-
RCTs, controlled before- and-after, and interrupted time series |
*All reviews were systematic literature reviews with pairwise meta-analysis, except for Yang 2011.
Recognizing the paucity of direct head-to-head randomized clinical trials (RCTs) between existing interventions, a network meta-analysis can be used to summarize the entirety of evidence for pregnancy interventions. A network of interventions connected via the comparisons that have been made in head-to-head trials can be constructed, and where there is a path from one intervention to another, these interventions can be compared indirectly via some common comparators 12– 16. In addition, where both direct and indirect evidence exists, the indirect evidence can be used to strengthen the inferences for the particular comparison. This is particularly important for pregnancy interventions because many head-to-head trials of active interventions have limited sample sizes. Furthermore, network meta-analysis allows us to simultaneously analyze all potential treatment options and make full use of the available evidence within a single analysis.
The purpose of this study was to assess the comparative effectiveness across intervention domains in micronutrient supplements, balanced energy protein supplements, deworming, maternal education, and WASH interventions using network meta-analysis. Effectiveness of interventions are determined by the following outcome indicators: preterm birth, low birthweight, and birthweight for LMIC-based pregnant women.
Methods
Our analysis and report was designed and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) extension to network meta-analysis 17. The protocol for this study is registered on PROSPERO ( CRD42018110446).
Search strategy and selection criteria
The scope of our research study and the corresponding search strategy was developed after first reviewing the papers published in the Lancet’s 2013 Maternal and Child Nutrition series 1, 18, including the umbrella review on evidence-based interventions by Bhutta and colleagues 2, for an overview of the literature. Specifically, we reviewed the bibliography of Bhutta et al. 2013 2 for relevant systematic reviews, global health guidelines, and LMIC-based trials. We also performed hand searches on PubMed and the Cochrane Database of Systematic Reviews for reviews that have been published after 2013. The list of published reviews relevant to this study is provided in Table 1.
For our systematic literature search, the following databases were searched from inception to September 17, 2019: the Cochrane Central Register of Controlled Trials, Embase, and MEDLINE ( Extended data, Supplementary Tables 1–3) 19. In addition to database searches, we included the relevant trials identified from bibliographies of prior reviews ( Table 1). Table 2 describes the PICOS criteria used to guide the study selection. We included LMIC-based RCTs on interventions related to the domains of micronutrient supplements, balanced energy protein (i.e. food supplementation) supplements, deworming, maternal education, and WASH; the outcomes of interest were preterm birth (<37 weeks of gestational age), low birthweight (<2500 grams), and birthweight (continuous). We excluded non-English language studies.
Table 2. Population, interventions, comparator, outcomes, and study design criteria for study inclusion.
Category | Inclusion criteria |
---|---|
Population | Pregnant women living in low- and middle-income countries |
Intervention | • Micronutrient and calcium supplementation to mother
• Balanced energy protein (i.e. food) supplementation to mother • Deworming • Maternal education • Any water, sanitation and hygiene intervention |
Comparators | • Placebo
• Standard-of-care (if applicable) • No intervention • Any of the interventions listed above as monotherapy or in combination that can be used for indirect comparison |
Outcomes | At least one of the following outcomes:
• Preterm birth (<37 weeks of gestational age) • Low birthweight (<2500 g) • Birthweight (continuous) |
Study Design | Randomized clinical trials |
Other | Published in the English language |
A paired group of four reviewers (JJHP, ES, MZ, and LD) independently reviewed all abstracts and proceedings identified in the literature searches. JJHP and ES worked in one pair, while MZ and LD worked in another pair. The same paired team independently reviewed abstracts potentially relevant in full-text. If any discrepancies occurred between the studies selected by the two investigators, a third investigator (KT) provided arbitration.
Using a standardized data sheet, a paired group of four reviewers (JJHP, ES, MZ, and NEZ) independently extracted data for study characteristics, interventions used, patient characteristics at baseline, and outcomes from the final list of selected eligible studies. Any discrepancies observed between the data extracted by the four extractors were resolved by consensus through discussion. Primary outcomes were dichotomous, consisting of preterm birth and low birthweight. Our secondary endpoint was the continuous outcome of birthweight. We preferentially extracted intention-to-treat outcomes.
Data analysis
We performed our analyses within the Bayesian framework in R using the R2WinBUGS v14 package 39, 40. Bayesian models were performed according to the National Institute for Health and Care Excellence (NICE) in their Technical Support Document 2 (TSD2) 41. The network diagrams with respective to the analyzed outcome can be seen in Extended data, Supplementary Figures 1–6 19. Estimates of comparative effectiveness are measured using risk ratios (RRs) with associated 95% credible intervals (95% CrI) for preterm birth and low birthweight, and mean differences and the associated 95% CrI for birthweight. We performed random-effects network meta-analysis models using an empirically informative priors for the heterogeneity variance, as suggested by Rhodes et al. 42 for mean birthweight and Turner et al. 43 for preterm birth and low birthweight. This was done to stabilize the estimation of heterogeneity in the face of low number of trials per comparison in the network. Our model selection was informed by the deviance information criterion (DIC) and the deviance-leverage plots that could help identify outliers or lack of model fit.
As our primary analysis, we included both cluster and individually randomized (non-cluster) clinical trials. To adjust for clustering effects of the cluster trials, we adjusted the sample sizes and number of cases for preterm birth and low birthweight and inflated variances for mean birthweight to account for clustering effects of the cluster trials, as recommended by Uhlmann et al. 44, assuming a conservative intra-cluster correlation coefficient (ICC) value of 0.05. For each outcome, we performed sensitivity analyses by excluding cluster randomized clinical trials where the analyses were limited to individually randomized clinical trials only.
Risk of bias within and across studies
Each full text article was evaluated for reporting quality according to the Cochrane Risk of Bias Tool 45. The risk of bias assessment within and across studies are provided in the Extended data (Supplementary Table 8) 19.
Results
We identified 5,297 abstracts from our database searches and hand searches of the bibliography of the published reviews ( Figure 1). Of these, 377 studies underwent a full-text review, and 132 papers reporting on 101 trials met our inclusion criteria. In total, these trials included 206,531 pregnant women that were randomized to 245 unique interventions ( Figure 2). The list of included and excluded studies ( Extended data, Supplementary Tables 4 and 5) 19, as well as the trial and patient characteristics of the included studies ( Extended data, Supplementary Tables 6 and 7) 19 are provided in the Extended data. Geographically, most trials were conducted in South Eastern Asian (n = 38 trials) and African (n = 26 trials) countries, with individual randomization (i.e. non-cluster trials, n = 85 trials) and double blinding (n = 52 trials) being the most common methodological features. Micronutrient supplements was the most common intervention domain that was investigated (n = 79 trials); only a few of these micronutrient trials compared interventions from other domains, such as balanced energy protein supplements (n = 15 trials) and deworming (n = 6 trials). Maternal education was captured in a few trials (n=3) where the education component was in the form of counseling, lifestyle education, and participatory learning action (PLA) with government-mandated women’s groups. PLA involved awareness of the problem of LBW and malnutrition, and strategies to overcome barriers to improved health and nutrition. There were no WASH trials reporting on the analyzed birth outcomes.
In most trials, interventions were provided to pregnant women from enrollment until delivery (n = 87 trials). These trials generally involved women who were in the later part of their gestational age. For instance, only 5 trials enrolled women from or before conception (Owens 46, The women First Trial 47, CAP Trial 48, PRECONCEPT 49, and Brabin 50), while the majority of trials recruited women who were in the later trimesters, such as the 2 nd and 3 rd trimesters (n = 69 trials).
Preterm birth (<37 weeks of gestational age)
The preterm birth network ( Extended data, Supplementary Figure 1) 19 included 64 trials consisting of 85,546 pregnant women randomized to 152 intervention arms (ten cluster trials consisting of 1,998 clusters and 20,218 pregnant women). From the primary analysis, that included both cluster and non-cluster randomized clinical trials, only few interventions showed superiority over standard-of-care for preterm birth ( Figure 3). For instance, compared to standard-of-care, intake of 1500 kcal of local food per day showed an RR of 0.36 (95% CrI: 0.16, 0.77) and calcium showed an RR of 0.76 (95% CrI: 0.56, 0.99). Other micronutrient supplements such as folic acid (RR: 0.71, 95% CrI: 0.43, 1.09), iron (RR: 0.70, 95% CrI: 0.47, 1.01), zinc (RR: 0.67, 95% CrI: 0.41, 1.04), and multiple micronutrients (MMN) (RR: 0.70, 95% CrI: 0.45, 1.02) showed a trend towards lower preterm birth risks compared to standard-of-care, but their Crls overlapped the null effect of 1.00. In comparison to standard-of-care, no balanced energy food supplements, other than 1500 kcal of local food showed reduction in preterm birth risks, and neither did maternal education interventions (e.g. participatory learning action 51).
Mean birthweight (kg)
The mean birthweight network ( Extended data, Supplementary Figure 3) 19 included of 81 trials that consisted of 130,315 pregnant women randomized to 196 intervention arms. Of these 81 trials, 14 were cluster trials that randomized 1,354 clusters (57,483 pregnant women) to 35 intervention arms. The results of the network meta-analysis on mean birthweight can be found in Figure 4. Among the micronutrient supplementation domain, compared to standard-of-care, MMN (mean difference: 0.27 kg; 95% CrI: 0.09, 0.45 kg), folic acid (mean difference: 0.21 kg; 95% CrI: 0.00, 0.42 kg), iron (mean difference: 0.18 kg; 95% CrI: 0.02, 0.34 kg), and iron + folic acid (IFA) (mean difference: 0.18 kg; 95% CrI: 0.00, 0.36 kg) showed improvements in birthweight. Among the balanced energy food supplements, unfortified lipid-based nutrient supplements of 20 grams (LNS20) showed improvements in birthweight compared to standard-of-care (mean difference: 0.27 kg; 95% CrI: 0.03, 0.51 kg). Deworming and maternal education interventions did not improve mean birth weight; for instance, in comparison to standard-of-care, a single dose of deworming showed a mean difference of 0.02 kg (95% CrI: -0.16, 0.19 kg) and maternal education showed a mean difference of 0.07 kg (95% CrI: -0.27, 0.40 kg).
Low birthweight (<2.5 kg)
The low birthweight network ( Extended data, Supplementary Figure 5) 19 consisted of 67 trials, with 84,675 patients randomized to 160 intervention arms (eleven cluster trials consisting of 792 clusters and 9,512 pregnant women). The results on low birthweight (kg) outcome can be found in Figure 5. High caloric local food intervention (1500 kcal per day) reduced the risk of low birthweight (RR: 0.17; 95% CrI: 0.09; 0.29). There was a trend towards reduced risks of low birthweight for other interventions such as calcium (RR: 0.87; 95% CrI: 0.69; 1.07), MMN (RR: 0.73; 95% CrI: 0.49, 1.07), and LNS20 (RR: 0.65; 95% CrI: 0.39, 1.07), fortified LNS20 (RR: 0.72, 95% CrI: 0.48, 1.03), but their 95% CrI contained the null effect of 1.00. A single dose of deworming during pregnancy did not show reduction in low birthweight when compared to standard-of-care (RR: 1.15, 95% CrI: 0.83, 1.58).
Sensitivity analysis
For all three outcomes, the results from the sensitivity analyses of studies limited to non-cluster randomized clinical trials can be found in the Extended data (Supplementary cross table excel file: Sensitivity Preterm, LBW, and Birthweight tabs) 19. As fewer studies were available for the sensitivity analysis, the CrIs for many comparisons became wider, but the direction and the magnitude of comparative effects remained relatively stable. For instance, there were no individually randomized trials that evaluated the effectiveness of high caloric (1500 kcal per day) local food. In terms of micronutrient supplementation, MMN (mean difference: 0.10 kg; 95% CrI: 0.00, 0.20 kg) and iron (mean difference: 0.09 kg; 95% CrI: 0.02, 0.16 kg) improved mean birthweight by a small margin compared to standard-of-care. Similarly, unfortified lipid-based nutrient supplements (LNS20) did not improve mean birthweight to a great extent compared to standard-of-care (mean difference: 0.13 kg; 95% CrI: 0.01, 0.24 kg). Furthermore, in comparison to standard-of-care, maternal education (mean difference: 0.04 kg; 95% CrI: -0.13, 0.20 kg) and one dose of deworming (mean difference: 0.01 kg; 95% CrI: -0.04, 0.06 kg) did not have any effect on mean birthweight. As far as preterm birth is concerned, MMN (RR: 0.58; 95% CrI: 0.31, 1.00) showed a trend towards lower preterm birth risks compared to standard-of-care, but their Crls overlapped the null effect of 1.00.
Discussion
In this study, we used network meta-analysis to compare the effectiveness of interventions across several domains consisting of micronutrient supplements, balanced energy protein supplements, deworming, maternal education, and WASH interventions that can be provided to pregnant women living in LMICs. Several micronutrient supplements demonstrated decreased risks for preterm birth and/or improve mean birthweight, compared with standard-of-care for pregnant women. For example, MMN interventions showed reduction in preterm birth risks and improved mean birthweight. In comparison to standard-of-care, IFA, calcium, iron, and zinc also demonstrated a trend towards decreasing preterm birth risks. However, the evidence for other intervention domains were limited. For instance, among balanced energy protein supplements, only consumption of 1500 kcal of local food supplement lowered the risks of preterm birth and low birthweight; and only unfortified LNS 20 demonstrated improvement in mean birthweight. Nevertheless, these findings pertaining to balanced energy protein supplements corresponded to only three trials in the study 52– 54. There was a limited number of trials available for maternal education and deworming intervention; no WASH trials reporting on preterm birth and birthweight outcomes were available.
The main strength of this study was the use of network meta-analysis to assess the effectiveness of different interventions from a large network of evidence compared to standard-of-care. Unlike previous reviews that have focused on one intervention within a single domain, we used a broad evidence base that included multiple interventions from different domains. As well, appropriate statistical adjustments were made for clustering effects of cluster randomized clinical trials to enable the convergence of cluster and non-cluster trials for our network meta-analysis. Nevertheless, the existing evidence base limited our analyses. Few trials reported low birthweight, and the majority of randomized clinical trial evidence base was confined to a single domain of micronutrient supplementation. Another possible limitation was that there was notable variation in the enrollment of pregnant women in terms of trimesters and gestational age. While we did not find that time of enrollment relative to gestational age was a treatment effect modifier in our analyses, we acknowledge that this variation may have introduced heterogeneity in our meta-analyses. Prior evidence has also demonstrated mixed evidence as to whether the time at which treatment is initiated influences overall treatment efficacy, and this varies by treatment type 25, 31, 37. Lastly, our assumption of a conservative ICC (0.05) may also have affected the results. However, this was necessary in order to assess for the entire evidence base of interventions for pregnancy, as most cluster randomized trials did not report ICC for each outcome.
Despite these limitations, the findings of this study were generally similar to that of other existing reviews. For instance, among the micronutrient supplements, other reviews have shown that iron (RR=0.82, 95%Crl 0.72, 0.94) 55 and MMN (RR=0.88, 95%Crl 0.85, 0.90) 31 reduced the risks of low birthweight versus standard-of-care. Moreover, calcium (RR=0.76, 95%Crl 0.60, 0.97) 25 and zinc (RR=0.86, 95%Crl 0.76, 0.97) 37 supplements reduced the risks of preterm birth, and we have found that intake of combined MMN reduced the risks of preterm birth and improved mean birthweight. Similar to this study, Salam 26 found no improvements in low birthweight and preterm birth for deworming versus standard-of-care. There were no reviews on WASH available that looked at the role of WASH interventions on birthweight and preterm birth.
Our findings identified several directions for future research. First, there is a need to combine interventions that consist of compelling and evidence-based interventions of different domains as a package, moving away from a reductionist approach that is reflected in the majority of clinical trials conducted so far. Instead of a singling out interventions from one domain, there is a need for more evidence of packaged interventions because a combined set of interventions will likely result in the greatest improvement for adverse birth outcomes. Second, more research is needed to assess the longevity of interventions and its effectiveness across multiple life stages. For instance, only 17 out of 101 trials conducted follow-ups of women after birth delivery into the post-partum period. It is also important to note that the median follow-up of pregnant women beyond delivery was 8 weeks and only three trials 23, 56, 57 conducted follow-ups with women and their newborns up to 6 months of age.
Overall, we identified a number of interventions for pregnancy with clear and compelling supportive evidence for effectiveness for preventing adverse birth outcomes. In midst of the World Health Organization’s Global Nutrition Targets 2025 58, which focuses on improving maternal, infant, and young children nutrition, national and local MNCH programs should consider adopting and adapting effective interventions identified in this review based on their local resource availability and program priorities. This may provide an opportunity to evaluate the benefits of these interventions in routine practice for pregnancy, and a step towards reaching the 2025 Global Nutrition Target of reducing the global prevalence of low birthweight by 30% 59.
Data availability
Underlying data
All data underlying the results are available as part of the article and no additional source data are required.
Extended data
Open Science Framework: Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis.
https://doi.org/10.17605/OSF.IO/JK3AQ 19.
This project contains the following extended data:
-
Pregnancy NMA - Supplementary tables and figures - v2.0:
Appendix 1. Literature search strategy. (Contains Supplementary Tables 1–3.)
Appendix 2. Details of statistical analyses.
Appendix 3. List of included and excluded studies are full-text review. (Contains Supplementary Tables 4 and 5.)
Appendix 4. Details of the evidence base. (Contains Supplementary Tables 6 and 7.)
Appendix 5. Bias Assessment. (Contains Supplementary Table 8.)
Appendix 6. Intervention networks for birth outcomes (Supplementary Figures 1–6.)
Appendix 7. Primary analysis leverage and consistency plots. (Supplementary Figures 7–12.)
Appendix 8. Sensitivity analysis forest plots, non-cluster trials. (Supplementary Figures 13–15.)
Appendix 9. Sensitivity analysis leverage plots, non-cluster trials. (Supplementary Figures 16–18.)
Pregnancy NMA - Supplementary crosstables - v1.0
Reporting guidelines
Open Science Framework: PRISMA checklist for “Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis.” https://doi.org/10.17605/OSF.IO/JK3AQ 19.
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
Funding Statement
This study was supported by the Bill & Melinda Gates Foundation (Contract Number: 52565).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
[version 2; peer review: 1 approved, 2 approved with reservations]
References
- 1. Black RE, Victora CG, Walker SP, et al. : Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427–51. 10.1016/S0140-6736(13)60937-X [DOI] [PubMed] [Google Scholar]
- 2. Bhutta ZA, Das JK, Rizvi A, et al. : Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost? Lancet. 2013;382(9890):452–77. 10.1016/S0140-6736(13)60996-4 [DOI] [PubMed] [Google Scholar]
- 3. Vaivada T, Gaffey MF, Das JK, et al. : Evidence-based interventions for improvement of maternal and child nutrition in low-income settings: what's new? Curr Opin Clin Nutr Metab Care. 2017;20(3):204–10. 10.1097/MCO.0000000000000365 [DOI] [PubMed] [Google Scholar]
- 4. Gernand AD, Schulze KJ, Stewart CP, et al. : Micronutrient deficiencies in pregnancy worldwide: health effects and prevention. Nat Rev Endocrinol. 2016;12(5):274–89. 10.1038/nrendo.2016.37 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Darnton-Hill I, Mkparu UC: Micronutrients in pregnancy in low- and middle-income countries. Nutrients. 2015;7(3):1744–68. 10.3390/nu7031744 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Campbell OM, Benova L, Gon G, et al. : Getting the basic rights - the role of water, sanitation and hygiene in maternal and reproductive health: a conceptual framework. Trop Med Int Health. 2015;20(3):252–67. 10.1111/tmi.12439 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Sappenfield E, Jamieson DJ, Kourtis AP: Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. 2013;2013:752852. 10.1155/2013/752852 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Campbell SJ, Nery SV, Wardell R, et al. : Water, Sanitation and Hygiene (WASH) and environmental risk factors for soil-transmitted helminth intensity of infection in Timor-Leste, using real time PCR. PLoS Negl Trop Dis. 2017;11(3):e0005393. 10.1371/journal.pntd.0005393 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Benova L, Cumming O, Campbell OM: Systematic review and meta-analysis: association between water and sanitation environment and maternal mortality. Trop Med Int Health. 2014;19(4):368–87. 10.1111/tmi.12275 [DOI] [PubMed] [Google Scholar]
- 10. Christian P: Fetal growth restriction and preterm as determinants of child growth in the first two years and potential interventions. Nestle Nutr Inst Workshop Ser.Karger Publishers.2014:78:81–91. 10.1159/000354943 [DOI] [PubMed] [Google Scholar]
- 11. Sinha B, Taneja S, Chowdhury R, et al. : Low-birthweight infants born to short-stature mothers are at additional risk of stunting and poor growth velocity: Evidence from secondary data analyses. Matern Child Nutr. 2018;14(1):e12504. 10.1111/mcn.12504 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Kanters S, Ford N, Druyts E, et al. : Use of network meta-analysis in clinical guidelines. Bull World Health Organ. 2016;94(10):782–4. 10.2471/BLT.16.174326 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Thorlund K, Druyts E, Toor K, et al. : Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs. Expert Rev Gastroenterol Hepatol. 2015;9(5):693–700. 10.1586/17474124.2015.1024657 [DOI] [PubMed] [Google Scholar]
- 14. Hutton B, Salanti G, Chaimani A, et al. : The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement. PLoS One. 2014;9(3):e92508. 10.1371/journal.pone.0092508 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Mills EJ, Thorlund K, Ioannidis JP: Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914. 10.1136/bmj.f2914 [DOI] [PubMed] [Google Scholar]
- 16. Zafari Z, Thorlund K, FitzGerald JM, et al. : Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes. Pharmacoeconomics. 2014;32(10):995–1004. 10.1007/s40273-014-0179-1 [DOI] [PubMed] [Google Scholar]
- 17. Hutton B, Salanti G, Caldwell DM, et al. : The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–84. 10.7326/M14-2385 [DOI] [PubMed] [Google Scholar]
- 18. Ruel MT, Alderman H, Maternal and Child Nutrition Study Group: Nutrition-sensitive interventions and programmes: how can they help to accelerate progress in improving maternal and child nutrition? Lancet. 2013;382(9891):536–51. 10.1016/S0140-6736(13)60843-0 [DOI] [PubMed] [Google Scholar]
- 19. Park JJ, Harari O, Siden E, et al. : Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis.2019. 10.17605/OSF.IO/JK3AQ [DOI] [PMC free article] [PubMed]
- 20. Imdad A, Bhutta ZA: Effect of balanced protein energy supplementation during pregnancy on birth outcomes. BMC Public Health. 2011;11 Suppl 3:S17. 10.1186/1471-2458-11-S3-S17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Imdad A, Bhutta ZA: Maternal nutrition and birth outcomes: effect of balanced protein-energy supplementation. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:178–90. 10.1111/j.1365-3016.2012.01308.x [DOI] [PubMed] [Google Scholar]
- 22. Liberato SC, Singh G, Mulholland K: Effects of protein energy supplementation during pregnancy on fetal growth: a review of the literature focusing on contextual factors. Food Nutr Res. 2013;57. 10.3402/fnr.v57i0.20499 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Stevens B, Buettner P, Watt K, et al. : The effect of balanced protein energy supplementation in undernourished pregnant women and child physical growth in low- and middle-income countries: a systematic review and meta-analysis. Matern Child Nutr. 2015;11(4):415–32. 10.1111/mcn.12183 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Buppasiri P, Lumbiganon P, Thinkhamrop J, et al. : Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes. Cochrane Database Syst Rev. 2015; (2):CD007079. 10.1002/14651858.CD007079.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Hofmeyr GJ, Lawrie TA, Atallah AN, et al. : Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2014; (6):CD001059. 10.1002/14651858.CD001059.pub4 [DOI] [PubMed] [Google Scholar]
- 26. Salam RA, Haider BA, Humayun Q, et al. : Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy. Cochrane Database Syst Rev. 2015; (6):CD005547. 10.1002/14651858.CD005547.pub3 [DOI] [PubMed] [Google Scholar]
- 27. Lassi ZS, Salam RA, Haider BA, et al. : Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev. 2013; (3):CD006896. 10.1002/14651858.CD006896.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Yang Z, Huffman SL: Review of fortified food and beverage products for pregnant and lactating women and their impact on nutritional status. Matern Child Nutr. 2011;7 Suppl 3:19–43. 10.1111/j.1740-8709.2011.00350.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Peña-Rosas JP, Viteri FE: Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev. 2009; (4):CD004736. 10.1002/14651858.CD004736.pub3 [DOI] [PubMed] [Google Scholar]
- 30. Suchdev PS, Peña-Rosas JP, De-Regil LM: Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women. Cochrane Database Syst Rev. 2015; (6):CD011158. 10.1002/14651858.CD011158.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Haider BA, Bhutta ZA: Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2017;4:CD004905. 10.1002/14651858.CD004905.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Imhoff-Kunsch B, Briggs V, Goldenberg T, et al. : Effect of n-3 long-chain polyunsaturated fatty acid intake during pregnancy on maternal, infant, and child health outcomes: a systematic review. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:91–107. 10.1111/j.1365-3016.2012.01292.x [DOI] [PubMed] [Google Scholar]
- 33. Thorne-Lyman AL, Fawzi WW: Vitamin A and carotenoids during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:36–54. 10.1111/j.1365-3016.2012.01284.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. De-Regil LM, Palacios C, Lombardo LK, et al. : Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016; (1):CD008873. 10.1002/14651858.CD008873.pub3 [DOI] [PubMed] [Google Scholar]
- 35. Pérez-López FR, Pasupuleti V, Mezones-Holguin E, et al. : Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2015;103(5):1278–88 e4. 10.1016/j.fertnstert.2015.02.019 [DOI] [PubMed] [Google Scholar]
- 36. Thorne-Lyman A, Fawzi WW: Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2012;26 Suppl 1:75–90. 10.1111/j.1365-3016.2012.01283.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Ota E, Mori R, Middleton P, et al. : Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database Syst Rev. 2015; (2):CD000230. 10.1002/14651858.CD000230.pub5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Goudet SM, Bogin BA, Madise NJ, et al. : Nutritional interventions for preventing stunting in children (birth to 59 months) living in urban slums in low- and middle-income countries (LMIC). Cochrane Database Syst Rev. 2019;6:CD011695. 10.1002/14651858.CD011695.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. R Development Core Team: R: A Language Environment for Statistical Computing. In: Team RC, editor. Vienna, Austria: R Foundation for Statistical Computing2017. Reference Source [Google Scholar]
- 40. Sturtz S, Ligges U, Gelman A: R2OpenBUGS: a package for running OpenBUGS from R. J Stat Softw. 2005;12(3):1–16. Reference Source [Google Scholar]
- 41. Dias S, Sutton AJ, Ades AE, et al. : Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33(5):607–17. 10.1177/0272989X12458724 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Rhodes KM, Turner RM, Higgins JP: Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data. J Clin Epidemiol. 2015;68(1):52–60. 10.1016/j.jclinepi.2014.08.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Turner RM, Jackson D, Wei Y, et al. : Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis. Stat Med. 2015;34(6):984–98. 10.1002/sim.6381 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Uhlmann L, Jensen K, Kieser M: Bayesian network meta-analysis for cluster randomized trials with binary outcomes. Res Synth Methods. 2017;8(2):236–50. 10.1002/jrsm.1210 [DOI] [PubMed] [Google Scholar]
- 45. Higgins JPT, Chandler J, Cumpston M, et al. : Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane Reviews. 2019. Reference Source [Google Scholar]
- 46. Owens S, Gulati R, Fulford AJ, et al. : Periconceptional multiple-micronutrient supplementation and placental function in rural Gambian women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2015;102(6):1450–9. 10.3945/ajcn.113.072413 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Hambidge KM, Westcott JE, Garces A, et al. : A multicountry randomized controlled trial of comprehensive maternal nutrition supplementation initiated before conception: the Women First trial. Am J Clin Nutr. 2019;109(2):457–69. 10.1093/ajcn/nqy228 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Hofmeyr G, Betrán AP, Singata-Madliki M, et al. : Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019;393(10169):330–339. 10.1016/S0140-6736(18)31818-X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Ramakrishnan U, Nguyen PH, Gonzalez-Casanova I, et al. : Neither Preconceptional Weekly Multiple Micronutrient nor Iron-Folic Acid Supplements Affect Birth Size and Gestational Age Compared with a Folic Acid Supplement Alone in Rural Vietnamese Women: A Randomized Controlled Trial. J Nutr. 2016;146(7):1445S–52S. 10.3945/jn.115.223420 [DOI] [PubMed] [Google Scholar]
- 50. Brabin B, Gies S, Roberts SA, et al. : Excess risk of preterm birth with periconceptional iron supplementation in a malaria endemic area: analysis of secondary data on birth outcomes in a double blind randomized controlled safety trial in Burkina Faso. Malar J. 2019;18(1):161. 10.1186/s12936-019-2797-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Saville NM, Shrestha BP, Style S, et al. : Impact on birth weight and child growth of Participatory Learning and Action women's groups with and without transfers of food or cash during pregnancy: Findings of the low birth weight South Asia cluster-randomised controlled trial (LBWSAT) in Nepal. PLoS One. 2018;13(5):e0194064. 10.1371/journal.pone.0194064 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Tabrizi JS, Asghari A, Pourali F, et al. : Effects of Food Supplementation During Pregnancy on Maternal Weight Gain, Hemoglobin Levels and Pregnancy Outcomes in Iran. Matern Child Health J. 2019;23(2):258–64. 10.1007/s10995-018-2648-1 [DOI] [PubMed] [Google Scholar]
- 53. Adu-Afarwuah S, Lartey A, Okronipa H, et al. : Lipid-based nutrient supplement increases the birth size of infants of primiparous women in Ghana. Am J Clin Nutr. 2015;101(4):835–46. 10.3945/ajcn.114.091546 [DOI] [PubMed] [Google Scholar]
- 54. Ashorn P, Alho L, Ashorn U, et al. : Supplementation of Maternal Diets during Pregnancy and for 6 Months Postpartum and Infant Diets Thereafter with Small-Quantity Lipid-Based Nutrient Supplements Does Not Promote Child Growth by 18 Months of Age in Rural Malawi: A Randomized Controlled Trial. J Nutr. 2015;145(6):1345–53. 10.3945/jn.114.207225 [DOI] [PubMed] [Google Scholar]
- 55. Haider BA, Olofin I, Wang M, et al. : Anaemia, prenatal iron use, and risk of adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2013;346:f3443. 10.1136/bmj.f3443 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Ahmad SM, Hossain MB, Monirujjaman M, et al. : Maternal zinc supplementation improves hepatitis B antibody responses in infants but decreases plasma zinc level. Eur J Nutr. 2016;55(5):1823–9. 10.1007/s00394-015-0999-6 [DOI] [PubMed] [Google Scholar]
- 57. Nair N, Tripathy P, Sachdev HS, et al. : Effect of participatory women's groups and counselling through home visits on children's linear growth in rural eastern India (CARING trial): a cluster-randomised controlled trial. Lancet Glob Health. 2017;5(10):e1004–e16. 10.1016/S2214-109X(17)30339-X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. WHO Global Targets 2025.2019. Reference Source [Google Scholar]
- 59. Dhillon S: Roxadustat: First Global Approval. Drugs. 2019;79(5):563–72. 10.1007/s40265-019-01077-1 [DOI] [PubMed] [Google Scholar]